Targets › LTF
2 programs from 2 companies in 4 trials: 3 Phase 3, 1 Phase 2; Hematology, Gastroenterology; next expected readout Dec 2026.
Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate..; FUNCTION: [Lactotransferrin]: Major iron-binding and multifunctional protein found in exocrine fluids such as breast milk and mucosal secretions. Has antimicrobial activity, which depends on the extracellular cation concentration. (UniProt, P02788)
Open in Phaseline: the race on LTF, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| University of Washington | Lactoferrin Combination of iron-binding glycoprotein and antimicrobial enzyme for enhanced intestinal | LTF, LYZ | Phase 3 | Diarrhea | Dec 2026 |
| Beni-Suef University | Lactoferrin Iron-binding protein; enhances iron absorption and utilization | LTF | Phase 2 | Iron Deficiency Anemia (IDA) | Dec 2026 |
Diarrhea (3) Iron Deficiency Anemia (IDA) (1)
small molecule (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.